Blood Test Detects Parkinson’s Disease Through Alpha Synuclein Biomarkers
Sunbird Bio demonstrated that its blood-based alpha synuclein biomarkers can accurately detect Parkinson’s disease.
Read MorePosted by Andy Lundin | Nov 8, 2024 | Dementias & Alzheimer’s, Molecular Diagnostics |
Sunbird Bio demonstrated that its blood-based alpha synuclein biomarkers can accurately detect Parkinson’s disease.
Read MorePosted by Andy Lundin | Nov 7, 2024 | Gastrointestinal Infections |
Castle Biosciences’ Barrett’s Esophagus test delivered over 25,000 reports to support risk assessment for Barrett’s Esophagus patients.
Read MorePosted by Andy Lundin | Nov 6, 2024 | Covid 19 |
Nasal autoantibodies can predict COVID severity, providing insights for personalized treatment and applications for other respiratory viruses.
Read MorePosted by Chris Wolski | Nov 1, 2024 | Dementias & Alzheimer’s |
Roche announced the Elecsys Amyloid Plasma Panel shows promising results in accurately ruling out amyloid pathology in Alzheimer’s disease.
Read MorePosted by Chris Wolski | Oct 31, 2024 | Dementias & Alzheimer’s |
Researchers have found a significant link between olfactory loss in 139 medical conditions, highlighting the role of smell plays.
Read More